Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Multiple Myeloma × Crizotinib × Clear all

Phase

Status

Active not recruiting 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 6 Colorectal Neoplasms 2 Uveal Melanoma 1 Rare Tumor 1 Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1

Interventions

Dexamethasone 72 Lenalidomide 44 daratumumab 40 Bortezomib 26 Cyclophosphamide 25 pomalidomide 24 carfilzomib 21 Calcium Dobesilate 20 talquetamab 17 fludarabine 16 Specimen Handling 15 Magnetic Resonance Spectroscopy 15 iberdomide 14 Biopsy 14 isatuximab 13 belantamab mafodotin 12 selinexor 9 elotuzumab 9 dexamethasone acetate 9 dexamethasone 21-phosphate 8 auricularum 8 Melphalan 8 venetoclax 6 X-Rays 6 Blood Specimen Collection 5 tocilizumab 4 pegylated granulocyte colony-stimulating factor 4 ixazomib 4 fludarabine phosphate 4 Nivolumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297606 2026-03-04

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡